{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:39:43Z","timestamp":1787981983805,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/idoj.idoj_325_18","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T08:54:17Z","timestamp":1558083257000},"page":"251","source":"Crossref","is-referenced-by-count":10,"title":["Clinical profile of cutaneous adverse effects of epidermal growth factor receptor inhibitors: A prospective observational study of 76 cases"],"prefix":"10.4103","volume":"10","author":[{"given":"Aradhana","family":"Sood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerja","family":"Saraswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sushil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.258602-1","first-page":"317","volume-title":"Cutaneous side effects of epidermal growth factors inhibitors: Clinical presentation and management","author":"Hu","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.258602-2","first-page":"16","volume-title":"The EGFR as a target for anticancer therapy-focus on Cetuximab","author":"Baselga","year":"2001","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/2229-5178.258602-3","first-page":"958","volume-title":"Screening foe epidermal growth factor receptor mutations in lung cancer","author":"Rosell","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2229-5178.258602-4","first-page":"139","volume-title":"Epidermal growth factor receptor inhibitors: A new prospective in the treatment of lung cancer","author":"Tiseo","year":"2004","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"key-10.4103\/2229-5178.258602-5","first-page":"1160","volume-title":"EGFR antagonists in cancer treatment","author":"Ciardiello","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2229-5178.258602-6","first-page":"369","volume-title":"Epidermal growth factor receptor targetting in cancer","author":"Mendelsohn","year":"2006","journal-title":"Semin Oncol"},{"key":"key-10.4103\/2229-5178.258602-7","first-page":"152","volume-title":"Impact and management of skin toxicities with anti- epidermal growth factors receptor therapy: Survey results","author":"Boone","year":"2007","journal-title":"Oncology"},{"key":"key-10.4103\/2229-5178.258602-8","unstructured":"Available from: http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/Archive\/CTCAE_4.02_2009-09-15_QuickReference_5x7_Locked.pdf. [Last accessed on 2009 Sep 10]."},{"key":"key-10.4103\/2229-5178.258602-9","first-page":"4057","volume-title":"Biology of interactions: Antiepidermal growth factor receptor agents","author":"Harari","year":"2007","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/2229-5178.258602-10","doi-asserted-by":"crossref","unstructured":"Hynes NE, Lane HA. ERBB receptor and cancer: The complexity of targeted inhibitors. Nat Rev Cancer 2005;5341-54.","DOI":"10.1038\/nrc1609"},{"key":"key-10.4103\/2229-5178.258602-11","first-page":"239","volume-title":"Differences in human skin between the epidermal growth factor receptor distribution detected by EGF binding and monoclonal antibody recognition","author":"Green","year":"1985","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/2229-5178.258602-12","first-page":"31","volume-title":"Acneiform rash induced by EGFR inhibitors: Review of the literature and new insights","author":"Fabbrocini","year":"2015","journal-title":"Skin Appendage Disord"},{"key":"key-10.4103\/2229-5178.258602-13","first-page":"547","volume-title":"Cutaneous adverse events of epidermal growth factor inhibitors: A retrospective review of 99 cases","author":"Chanprapaph","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.258602-14","first-page":"271","volume-title":"Dermatological side effects of epidermal growth factor receptor inhibitors: 'PRIDE' complex","author":"Madke","year":"2014","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/2229-5178.258602-15","first-page":"1425","volume-title":"Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor inhibitors","author":"Segaert","year":"2005","journal-title":"Ann Oncol"},{"key":"key-10.4103\/2229-5178.258602-16","first-page":"657","volume-title":"Dermatologic side effects associated with epidermal growth factor inhibitor","author":"Agero","year":"2006","journal-title":"J Am Acad Dermato"},{"key":"key-10.4103\/2229-5178.258602-17","first-page":"107","volume-title":"Skin toxicities associated with epidermal growth factor receptor inhibitors","author":"Li","year":"2009","journal-title":"Target Onco"},{"key":"key-10.4103\/2229-5178.258602-18","first-page":"559","volume-title":"Unerwunschte kunate arzneimittelwirkungen von EGF-rezeptor-antagonisten and deren behandlung","author":"Klein","year":"2006","journal-title":"Allergo J"},{"key":"key-10.4103\/2229-5178.258602-19","first-page":"958","volume-title":"Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia","author":"Eames","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/2229-5178.258602-20","first-page":"149","volume-title":"Cutaneous side effects of EGFR Inhibitors--appearance and management","author":"Wollenberg","year":"2010","journal-title":"Dtsch Med Wochenschr"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:36:38Z","timestamp":1786732598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.IDOJ_325_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"alternative-id":["258602"],"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_325_18","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}